{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:38:41Z","timestamp":1761536321076,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1111\/jth.15833","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T23:09:52Z","timestamp":1663628992000},"page":"2444-2445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cA personalized limited sampling approach to better estimate terminal half\u2010life of FVIII concentrates\u201d: Comment from Huang et al."],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1641-1472","authenticated-orcid":false,"given":"Kun","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5273-145X","authenticated-orcid":false,"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-209X","authenticated-orcid":false,"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15833_bb0010","first-page":"1","article-title":"A personalized limited sampling approach to better estimate terminal half\u2010life of FVIII concentrates","author":"Chelle","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15833_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15833_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.thromres.2018.12.027","article-title":"Bayesian pharmacokinetic\u2010guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A","volume":"174","author":"Meg\u00edas\u2010Vericat","year":"2019","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15833_bb0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/rth2.12305","article-title":"Pharmacokinetic\u2010tailored approach to hemophilia prophylaxis: medical decision making and outcomes","volume":"4","author":"Croteau","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15833_bb0030","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/jth.14153","article-title":"Pharmacokinetics and the transition to extended half\u2010life factor concentrates: communication from the SSC of the ISTH","volume":"16","author":"Ragni","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15833_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ped4.12252","article-title":"Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A","volume":"5","author":"Chen","year":"2021","journal-title":"Pediatr Investig"},{"key":"10.1111\/jth.15833_bb0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thromres.2022.03.008","article-title":"Inter\u2010individual variability in pharmacokinetics and clinical features in pediatric patients with severe hemophilia A","volume":"213","author":"Huang","year":"2022","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15833_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12686","article-title":"Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia a after switching to Kovaltry from other standard half\u2010life factor VIII concentrates","volume":"6","author":"Huang","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"10.1111\/jth.15833_bb0050","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/hae.13192","article-title":"Population pharmacokinetic characterization of BAY 81\u20138973, a full\u2010length recombinant factor VIII: lessons learned \u2013 importance of including samples with factor VIII levels below the quantitation limit","volume":"23","author":"Garmann","year":"2017","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15833_bb0055","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1111\/hae.14336","article-title":"Pharmacokinetic\u2010guided prophylaxis improved clinical outcomes in paediatric patients with severe haemophilia A","volume":"27","author":"Huang","year":"2021","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15833","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15833","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622190598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622190598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:36:37Z","timestamp":1761536197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622190598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1538783622190598"],"URL":"https:\/\/doi.org\/10.1111\/jth.15833","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cA personalized limited sampling approach to better estimate terminal half\u2010life of FVIII concentrates\u201d: Comment from Huang et al.","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}